Dalvance (dalbavancin) Receives FDA Approval to Treat Acute Bacterial Skin and Skin Structure Infections in Pediatric Patients

NORTH CHICAGO, Ill., July 23, 2021 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) approved Dalvance® (dalbavancin) for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in pediatric patients from birth. Dalvance is the first single-dose option administered as a 30-minute intravenous (IV) infusion for… Read More: Dalvance (dalbavancin) Receives FDA Approval to Treat Acute Bacterial Skin… »

Easy way to dramatically reduce energy needs of homes

When analysing a business, there are three main ways to make it more profitable. Reduce expenses; increase sales or increase profit margins. Often a business coach or accountant will focus on one of those areas in particular when trying to improve the bottom line of any business. Of course the Holy Grail is when you… Read More: Easy way to dramatically reduce energy needs of homes »

A Cure for Allergies? Chicagoland Pediatrician May Have The Key

Itching and watery eyes, perhaps so swollen that it’s actually scary. Ragged and wheezy breathing. Sneezes so constant the shoulders and back begin to ache. For those with environmental allergies, this is their reality for most of the year, from spring until the first frost. When you’re the parent of a child who suffers from… Read More: A Cure for Allergies? Chicagoland Pediatrician May Have The Key »

CDC Monitors Potential Monkeypox Exposure in U.S.

July 23, 2021 As public health officials keep track of the contagious Delta variant of COVID-19 across the U.S., the CDC is also watching for a potential outbreak of another virus — monkeypox. More than 200 people in 27 states are being monitored for possible exposure after they had contact with an American who contracted… Read More: CDC Monitors Potential Monkeypox Exposure in U.S. »